Sucampo Pharmaceuticals, Inc. 4
4 · Sucampo Pharmaceuticals, Inc. · Filed Dec 29, 2016
Insider Transaction Report
Form 4
Ueno Ryuji
DirectorCEO, Chief Scientific Officer10% Owner
Transactions
- Gift
Class A Common Stock
2016-12-19−130,760→ 0 total(indirect: By Trust)
Holdings
- 9,006,585(indirect: By LLC)
Class A Common Stock